Apaxen has established strategic collaborations and partnerships with main academic research centers specialized in NLRP3 inflammasomes and in pulmonary arterial hypertension (PAH). We are looking for additional partnership opportunities regarding our preclinical programs in the field of chronic inflammation.

If you are interested in exploring partnership opportunities with Apaxen, please contact us at